Falk R, Free M, Ciavatta D, Chen D, Derebail V
Rheumatology (Oxford). 2025; 64(Supplement_1):i2-i10.
PMID: 40071421
PMC: 11897696.
DOI: 10.1093/rheumatology/keae613.
Liu C, Ge P, Mou S, Pang Y, Chan L, Li J
BMC Immunol. 2025; 26(1):19.
PMID: 40065209
PMC: 11892264.
DOI: 10.1186/s12865-025-00699-3.
Lin J, Wang Z, Wang H, Li Y, Liu Y, He Y
Int J Microbiol. 2024; 2024:1220644.
PMID: 39483642
PMC: 11527542.
DOI: 10.1155/2024/1220644.
Zhang Q, Han X, Bi Z, Yang M, Lin J, Li Z
Front Immunol. 2024; 15:1397916.
PMID: 39346912
PMC: 11427316.
DOI: 10.3389/fimmu.2024.1397916.
Liu L, Deng D, Li C, Huang G, Zhang W, Liang T
J Nanobiotechnology. 2024; 22(1):432.
PMID: 39034393
PMC: 11265141.
DOI: 10.1186/s12951-024-02722-y.
Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis.
Dubik M, Marczynska-Grzelak J, Sorensen M, Dieu R, Rusin D, Schioth E
Int J Mol Sci. 2024; 25(13).
PMID: 39000569
PMC: 11242768.
DOI: 10.3390/ijms25137462.
Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis.
Hopner L, Proschmann U, Inojosa H, Ziemssen T, Akgun K
Front Immunol. 2024; 15:1404316.
PMID: 38938576
PMC: 11208457.
DOI: 10.3389/fimmu.2024.1404316.
Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
Shao C, Xia N, Zhen Y, Zhang X, Yan N, Guo Q
Front Immunol. 2024; 15:1404828.
PMID: 38745647
PMC: 11091831.
DOI: 10.3389/fimmu.2024.1404828.
Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
Liphaus B, Silva S, Palmeira P, Silva C, Goldenstein-Schainberg C, Carneiro-Sampaio M
Front Immunol. 2024; 15:1327255.
PMID: 38562920
PMC: 10982494.
DOI: 10.3389/fimmu.2024.1327255.
Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study.
Xing X, Gan Y, Mo W, Zhang J, Wang N, Zhang K
Clin Rheumatol. 2024; 43(3):1145-1154.
PMID: 38326675
DOI: 10.1007/s10067-024-06873-z.
Dendritic cells: the yin and yang in disease progression.
Jimenez-Cortegana C, Palomares F, Alba G, Santa-Maria C, de la Cruz-Merino L, Sanchez-Margalet V
Front Immunol. 2024; 14:1321051.
PMID: 38239364
PMC: 10794555.
DOI: 10.3389/fimmu.2023.1321051.
Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases.
Wu W, Shiu C, Tong T, Leung S, Hui C
J Immunol Res. 2023; 2023:8924603.
PMID: 38106519
PMC: 10723930.
DOI: 10.1155/2023/8924603.
[Interferon-α mediating the functional damage of CD56CD57natural killer cells in peripheral blood of systemic lupus erythematosuss].
Zhao X, Liu J, Huang H, Lu Z, Bai Z, Li X
Beijing Da Xue Xue Bao Yi Xue Ban. 2023; 55(6):975-981.
PMID: 38101777
PMC: 10723978.
Regulatory NK cells in autoimmune disease.
Bahadorian D, Mollazadeh S, Mirazi H, Faraj T, Kheder R, Esmaeili S
Iran J Basic Med Sci. 2023; 26(6):609-616.
PMID: 37275764
PMC: 10237161.
DOI: 10.22038/IJBMS.2023.68653.14969.
Circulating CXCR5 natural killer cells are expanded in patients with myasthenia gravis.
Ge M, Yang C, Li T, Du T, Zhang P, Li X
Clin Transl Immunology. 2023; 12(5):e1450.
PMID: 37223338
PMC: 10202622.
DOI: 10.1002/cti2.1450.
The Negative Impact of Triptolide on the Immune Function of Human Natural Killer Cells.
Wang N, Min X, Ma N, Zhu Z, Cao B, Wang Y
Pharmaceuticals (Basel). 2023; 16(3).
PMID: 36986557
PMC: 10057343.
DOI: 10.3390/ph16030458.
Five genes as diagnostic biomarkers of dermatomyositis and their correlation with immune cell infiltration.
Zhao X, Si S
Front Immunol. 2023; 14:1053099.
PMID: 36742332
PMC: 9889851.
DOI: 10.3389/fimmu.2023.1053099.
Circulating CCR6ILC proportions are lower in multiple sclerosis patients.
Aglas-Leitner F, Juillard P, Juillard A, Byrne S, Hawke S, Grau G
Clin Transl Immunology. 2022; 11(12):e1426.
PMID: 36578284
PMC: 9782758.
DOI: 10.1002/cti2.1426.
A decreased number of circulating regulatory T cells is associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.
Li H, Zhang S, Zhang J, Cheng T, Liu Y, Liu H
Immun Inflamm Dis. 2022; 10(12):e731.
PMID: 36444629
PMC: 9639458.
DOI: 10.1002/iid3.731.
Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis.
Aglas-Leitner F, Juillard P, Juillard A, Byrne S, Hawke S, Grau G
Sci Rep. 2022; 12(1):20411.
PMID: 36437270
PMC: 9701791.
DOI: 10.1038/s41598-022-24617-4.